The cardiopulmonary exercise testing market is growing as an essential tool for evaluating cardiac and pulmonary function during physical activity, providing insight into both respiratory and cardiovascular health. Cardiopulmonary exercise testing is widely used in hospitals, diagnostic centers, and specialty clinics to assess patients with symptoms such as breathlessness, fatigue, and exercise intolerance, aiding in diagnosing conditions such as heart failure, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension. Recent developments in this field focus on integrating advanced sensors and data analytics to improve accuracy and user-friendliness, enabling more precise monitoring of patients during exertion. Digital health technologies and wearable devices are also entering the cardiopulmonary exercise testing field, making testing more accessible and expanding its utility for at-home monitoring. The demand for these systems is driven by the rising prevalence of cardiovascular and respiratory disorders, coupled with increased awareness of preventive healthcare, positioning the market for continued growth and technological advancement in the coming years.
